Cardiol Therapeutics ($CRDL): A New Approach to Treating Inflammation in Heart Disease

Past Event Cardiol Therapeutics (CRDL) Fireside Chat at the H.C. Wainwright 4th Annual BioConnect Investor Conference at the NASDAQMay 19, 2026

Past Event Ellis Martin: Cardiol Therapeutics (CRDL) CEO David Elsley on Breakthrough Heart Disease TreatmentApr 28, 2026

Past Event Barchart Interview: Cardiol Therapeutics: The Heart Drug Story Retail Investors Aren't Talking About...Yet!Apr 14, 2026